Low muscle mass in the arms and legs, as well as sarcopenia (low muscle mass and strength), were each linked…
Articles by Andrea Lobo, PhD
Molecular changes linked to inflammation and how brain cells process proteins and genetic material may occur before the onset of…
Acelot has dosed the first healthy volunteer in a Phase 1a clinical trial testing ACE-2223, its investigational oral treatment…
Paradromics’ investigational Connexus brain-computer interface (BCI) enabled a woman with a progressive motor neuron disease to generate her own…
Among people living with amyotrophic lateral sclerosis (ALS), requests to be referred for medical assistance in dying, known…
Neurosense Therapeutics announced that it’s preparing a new drug submission to Health Canada — following a meeting with the…
A stem cell therapy conditionally approved in South Korea for treating amyotrophic lateral sclerosis (ALS) will remain available in…
People with a history of smoking may face a higher risk of developing amyotrophic lateral sclerosis (ALS) than non-smokers, according…
A post-marketing analysis of safety reports found that many of the strongest signals involving Qalsody (tofersen) in people with…
The first patient has been dosed in a Phase 1/2 clinical trial evaluating Leal Therapeutics‘ LTX-002, an antisense oligonucleotide…